Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.30 |
| ▸ | THPO | P40225 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | APEX1 | P27695 | 1/20 | 0.30 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14609913 | 0.79 | — | — | |
| SCHEMBL30385890 | 0.78 | FAAH (0.38) | — | |
| SCHEMBL16405045 | 0.77 | SLC1A3 (0.39) | ALDH1A1TSHRNFKB1THPOHSD17B10 | |
| SCHEMBL8090957 | 0.77 | SLC1A3 (0.39) | ALDH1A1TSHRNFKB1THPOHSD17B10 | |
| SCHEMBL7127933 | 0.77 | SLC1A3 (0.39) | ALDH1A1TSHRNFKB1THPOHSD17B10 | |
| SCHEMBL12807367 | 0.74 | — | — | |
| SCHEMBL16517746 | 0.74 | — | — | |
| SCHEMBL14893421 | 0.74 | ALDH1A1 (0.35) | ALDH1A1TSHR | |
| SCHEMBL11383067 | 0.72 | — | — | |
| SCHEMBL3895254 | 0.72 | ALDH1A1 (0.37) | ALDH1A1TSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024099095-A1 | DESULFURIZER FOR ABSORBING HYDROGEN SULFIDE AND ORGANIC SULFUR UNDER ATMOSPHERIC PRESSURE AND PREPARATION METHOD FOR AND USE OF DESULFURIZER | 中国石油天然气股份有限公司 | 2024-05-16 | — | — | WO | claimed |
| CN-118022517-A | Desulfurizing agent for absorbing hydrogen sulfide and organic sulfur under normal pressure and preparation method and application thereof | 中国石油天然气股份有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-113264932-A | Preparation method of zolpidem | 湖南千金湘江药业股份有限公司 | 2021-08-17 | — | — | CN | claimed |
| CN-114249723-B | Preparation method of zolpidem and key intermediate thereof | 鲁南制药集团股份有限公司 | 2025-02-07 | — | — | CN | disclosed |
| CN-114249668-B | Preparation method of zolpidem intermediate N, N-dimethyl-2-oxyacetamide | 鲁南制药集团股份有限公司 | 2024-08-23 | — | — | CN | disclosed |
| WO-2024099095-A1 | DESULFURIZER FOR ABSORBING HYDROGEN SULFIDE AND ORGANIC SULFUR UNDER ATMOSPHERIC PRESSURE AND PREPARATION METHOD FOR AND USE OF DESULFURIZER | 中国石油天然气股份有限公司 | 2024-05-16 | — | — | WO | disclosed |
| CN-118022517-A | Desulfurizing agent for absorbing hydrogen sulfide and organic sulfur under normal pressure and preparation method and application thereof | 中国石油天然气股份有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-114057727-B | Synthesis method of zolpidem intermediate | 株洲千金药业股份有限公司 | 2024-02-27 | — | — | CN | disclosed |
| CN-114057725-B | Synthesis method of zolpidem tartrate | 株洲千金药业股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| CN-116768884-A | Method for synthesizing zolpidem | 湖南大学 | 2023-09-19 | — | — | CN | disclosed |
| CN-116120309-A | Preparation method of zolpidem | 山东新时代药业有限公司 | 2023-05-16 | — | — | CN | disclosed |
| WO-2004087703-A1 | PROCESS FOR THE PREPARATION OF N,N,6-TRIMETHYL-2-(4-METHYLPHENYL)-IMIDAZO[1,2-A]PYRIDINE-3-ACETAMIDE | SUN PHARMACEUTICAL INDUSTRIES LIMITED (IN) | 2004-10-14 | — | — | WO | disclosed |
| WO-2004007496-A1 | PROCESS FOR THE PREPARATION OF IMIDAZO(1,2-A)PYRIDINE-3-ACETAMIDES | SCINOPHARM TAIWAN, LTD. (TW) | 2004-01-22 | — | — | WO | disclosed |
| US-20040010146-A1 | Process for the preparation imidazo[1,2-A]pyridine-3-acetamides | SCINOPHARM TAIWAN, LTD. | 2004-01-15 | — | — | US | disclosed |
| CN-1433413-A | Oxazolidinone derivatives and process for their preparation | DONG A PHARM CO LTD (KR) | 2003-07-30 | — | — | CN | disclosed |
| CN-1413212-A | Process for preparation of 6-methyl-2-(4-methyl-phenyl)-imidazo [1,2-a] pyrimidine-3-(N,N-dimethyl-acetamide) and intermediates | EGYT GYOGYSZERVEGYESZETI GYAR (HU) | 2003-04-23 | — | — | CN | disclosed |
| EP-1259509-A1 | PROCESS FOR THE PREPARATION OF 6-METHYL-2-(4-METHYL-PHENYL)-IMIDAZO 1,2-A]PYRIMIDINE-3-(N,N-DIMETHYL-ACETAMIDE) AND INTERMEDIATES | EGIS GYOGYSZERGYAR RT. (HU) | 2002-11-27 | — | — | EP | disclosed |
| WO-2001038327-A2 | PROCESS FOR THE PREPARATION OF 6-METHYL-2-(4-METHYL-PHENYL)-IMIDAZO[1,2-A]PYRIMIDINE-3-(N,N-DIMETHYL-ACETAMIDE) AND INTERMEDIATES | EGIS Gyógyszergyár Rt. (HU) | 2001-05-31 | — | — | WO | disclosed |
| US-5081114-A | STEROIDS | ROUSSEL UCLAF (FR) | 1992-01-14 | — | — | US | disclosed |
| US-4794185-A | TREATING CORRESPONDING CHLORO COMPOUND WITH REDUCING AGENT | SYNTHELABO (FR) | 1988-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040010146-A1 | Process for the preparation imidazo[1,2-A]pyridine-3-acetamides | AAK1, ACP3, AP2M1 | ALDH1A1 1115/4885TSHR 1309/4885NFKB1 3045/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.